4.7 Article

Loss of 2-spectrin prevents cardiomyocyte differentiation and heart development

Journal

CARDIOVASCULAR RESEARCH
Volume 101, Issue 1, Pages 39-47

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/cvr/cvt222

Keywords

2-Spectrin; TGF-; Cytoskeleton; Cardiogenesis

Funding

  1. National Cancer Center of Korea [NCC -1310660]
  2. Korea Healthcare Technology RD Project [A111334]
  3. National Research Foundation of Korea [2010-0021822]
  4. Korea Health Promotion Institute [A111334] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
  5. National Research Foundation of Korea [2010-0021822] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

2-Spectrin is an actin-binding protein that plays an important role in membrane integrity and the transforming growth factor (TGF)- signalling pathway as an adaptor for Smads. Loss of 2-spectrin in mice (Spnb2(/)) results in embryonic lethality with gastrointestinal, liver, neural, and heart abnormalities that are similar to those in Smad2(/)Smad3(/) mice. However, to date, the role of 2-spectrin in embryogenesis, particularly in heart development, has been poorly delineated. Here, we demonstrated that 2-spectrin is required for the survival and differentiation of cardiomyocytes, and its loss resulted in defects in heart development with failure of ventricular wall thickening. Disruption of 2-spectrin in primary muscle cells not only inhibited TGF-/Smad signalling, but also reduced the expression of the cardiomyocyte differentiation markers Nkx2.5, dystrophin, and -smooth muscle actin (-SMA). Furthermore, cytoskeletal networks of dystrophin, F-actin, and -SMA in cardiomyocytes were disorganized upon loss of 2-spectrin. In addition, deletion of 2-spectrin in mice (Spnb2(tm1a/tm1a)) prevented proper development of the heart in association with disintegration of dystrophin structure and markedly reduced survival. These data suggest that 2-spectrin deficiency leads to inactivation of TGF-/Smad signalling and contributes to dysregulation of the cell cycle, proliferation, differentiation, and the cytoskeletal network, and it leads to defective heart development. Our data demonstrate that 2-spectrin is required for proper development of the heart and that disruption of 2-spectrin is a potential underlying cause of congenital heart defects.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

New brain metastases after whole-brain radiotherapy of initial brain metastases in breast cancer patients: the significance of molecular subtypes (KROG 16-12)

Jae Sik Kim, Kyubo Kim, Wonguen Jung, Kyung Hwan Shin, Seock-Ah Im, Hee-Jun Kim, Yong Bae Kim, Jee Suk Chang, Jee Hyun Kim, Doo Ho Choi, Yeon Hee Park, Dae Yong Kim, Tae Hyun Kim, Byung Ock Choi, Sea-Won Lee, Suzy Kim, Jeanny Kwon, Ki Mun Kang, Woong-Ki Chung, Kyung Su Kim, Won Sup Yoon, Jin Hee Kim, Jihye Cha, Yoon Kyeong Oh, In Ah Kim

Summary: The study identified risk factors leading to new brain metastases following brain-directed treatment for initial metastases from breast cancer. Different tumor molecular subtypes were associated with rates of new brain metastases development and effectiveness of initial whole-brain radiotherapy, with anti-HER2 therapy significantly reducing new brain metastases in HER2+ patients.

BREAST CANCER RESEARCH AND TREATMENT (2021)

Article Oncology

Multi-Institutional Retrospective Study of Radiotherapy for Hepatocellular Carcinoma in the Caudate Lobe

Sung Uk Lee, Sang Min Yoon, Jason Chia-Hsien Cheng, Tae Hyun Kim, Bo Hyun Kim, Jin-hong Park, Jinhong Jung, Chiao-Ling Tsai, Yun Chiang, Joong-Won Park

Summary: This study evaluated the clinical outcomes of radiotherapy for hepatocellular carcinoma in the caudate lobe and found promising results in terms of effectiveness and safety. Radiotherapy showed high rates of freedom from local progression and overall survival, with low toxicity profiles. These findings suggest that radiotherapy may be a promising treatment option for hepatocellular carcinoma in the caudate lobe.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

Role of adjuvant radiotherapy in extrahepatic bile duct cancer: A multicenter retrospective study (Korean Radiation Oncology Group 18-14)

Kyubo Kim, Jeong Il Yu, Wonguen Jung, Tae Hyun Kim, Jinsil Seong, Woo Chul Kim, Jin Hwa Choi, Younghee Park, Bae Kwon Jeong, Byoung Hyuck Kim, Tae Gyu Kim, Jin Hee Kim, Hae Jin Park, Hyun Soo Shin, Jung Ho Im, Jin Seok Heo, Joon Oh Park, Jin-Young Jang, Do-Youn Oh, Sang Myung Woo, Woo Jin Lee, Eui Kyu Chie

Summary: This study evaluated the role of adjuvant radiotherapy after curative resection in patients with extrahepatic bile duct cancer. The results showed that adjuvant radiotherapy combined with chemotherapy improved survival outcomes of resected EHBD cancer patients, with the greatest benefit observed in patients receiving concurrent chemoradiotherapy followed by chemotherapy.

EUROPEAN JOURNAL OF CANCER (2021)

Article Medicine, General & Internal

RRM1 Expression as a Prognostic Biomarker for Unresectable or Recurrent Biliary Tract Cancer Treated with Gemcitabine plus Cisplatin

Jung Won Chun, Boyoung Lee, Weon Seo Park, Nayoung Han, Eun Kyung Hong, Eun Young Park, Sung Sik Han, Sang-Jae Park, Tae Hyun Kim, Woo Jin Lee, Sang Myung Woo

Summary: The study aimed to investigate the predictive and prognostic values of several biomarkers in patients with advanced biliary tract cancer treated with gemcitabine plus cisplatin. The results showed that increased intratumoral expression of RRM1 may predict poor survival in patients with this chemotherapy regimen.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Oncology

Dosimetric Comparisons between Proton Beam Therapy and Modern Photon Radiation Techniques for Stage I Non-Small Cell Lung Cancer According to Tumor Location

Unurjargal Bayasgalan, Sung Ho Moon, Tae Hyun Kim, Tae Yoon Kim, Seung Hyun Lee, Yang-Gun Suh

Summary: This study investigated the dosimetric benefits of proton beam therapy (PBT) compared to modern photon radiation techniques for stage I non-small cell lung cancer (NSCLC) patients, based on tumor location (central, peripheral, and close to the chest wall). The results showed that PBT significantly reduced radiation exposure to the lung and heart in all locations, indicating its potential benefits for reducing toxicities in these organs.

CANCERS (2021)

Article Oncology

Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)

Sung Uk Lee, Jinsil Seong, Tae Hyun Kim, Jung Ho Im, Woo Chul Kim, Kyubo Kim, Hae Jin Park, Tae Gyu Kim, Youngkyong Kim, Bae Kwon Jeong, Jin Hee Kim, Byoung Hyuck Kim, Taek-Keun Nam

Summary: The effectiveness of adjuvant treatments for resected gallbladder carcinoma remains uncertain due to lack of randomized controlled trials. Chemoradiotherapy (CRT) is valuable as adjuvant treatment for stage III-IV disease, while further study is needed for stage II disease with high-risk features.

CANCER BIOLOGY & MEDICINE (2022)

Article Biology

DAF-2c signaling promotes taste avoidance after starvation in Caenorhabditis elegans by controlling distinct phospholipase C isozymes

Masahiro Tomioka, Moon Sun Jang, Yuichi Iino

Summary: This study investigates the function of the DAF-2c signaling pathway in salt avoidance after starvation conditioning in Caenorhabditis elegans. The results suggest that taste avoidance behavior may rely on the control of distinct PLC isozymes via DAF-2c.

COMMUNICATIONS BIOLOGY (2022)

Article Oncology

Proton Beam Therapy versus Photon Radiotherapy for Stage I Non-Small Cell Lung Cancer

Yang-Gun Suh, Jae Myoung Noh, Doo Yeul Lee, Tae Hyun Kim, Unurjargal Bayasgalan, Hongryull Pyo, Sung Ho Moon

Summary: Proton beam therapy (PBT) was compared with photon radiotherapy for stage I non-small cell lung cancer (NSCLC) in terms of clinical outcomes and dosimetry. Data from patients who underwent PBT or photon radiotherapy at two Korean institutions were analyzed. Multivariate Cox proportional hazards models and propensity score-matched analyses were used to compare local progression-free survival (PFS) and overall survival (OS). Survival and radiation exposure to the lungs were compared in the matched population. Of the 289 patients included, 112 underwent PBT and 177 underwent photon radiotherapy. With a median follow-up of 27 months, the 2-year local PFS and OS rates were 94.0% and 83.0%, respectively. Multivariate analysis showed a biologically effective dose (BED10, using alpha/beta = 10 Gy) of >= 125 cobalt gray equivalents was significantly associated with improved local PFS and OS. In the matched analyses, the local PFS and OS did not differ between groups. However, PBT showed significantly lower lung and heart radiation exposure in terms of mean dose, V5, and V10 compared to photon radiotherapy. PBT reduced radiation exposure to the heart and lungs without worsening disease control in stage I NSCLC patients.

CANCERS (2022)

Article Oncology

Dose Profile Modulation of Proton Minibeam for Clinical Application

Myeongsoo Kim, Ui-Jung Hwang, Kyeongyun Park, Dohyeon Kim, Hak Soo Kim, Sang Hyoun Choi, Jong Hwi Jeong, Dongho Shin, Se Byeong Lee, Joo-Young Kim, Tae Hyun Kim, Hye Jung Baek, Hojin Kim, Kihwan Kim, Sang Soo Kim, Young Kyung Lim

Summary: The study aims to implement proton minibeam radiation therapy (pMBRT) in clinical proton therapy facilities using a multislit collimator (MSC) and a scattering device. Through simulation and experiments, it has been shown that the combination of MSC and scatterers can successfully achieve pMBRT and demonstrate consistent patterns in dose distribution.

CANCERS (2022)

Article Oncology

Proton Beam Therapy for Treatment-Naive Hepatocellular Carcinoma and Prognostic Significance of Albumin-Bilirubin (ALBI) Grade

Tae Hyun Kim, Bo Hyun Kim, Joong-Won Park, Yu Ri Cho, Young-Hwan Koh, Jung Won Chun, Eun Sang Oh, Do Yeul Lee, Sung Uk Lee, Yang-Gun Suh, Sang Myung Woo, Sung Ho Moon, Sang Soo Kim, Woo Jin Lee

Summary: In this study, the efficacy of PBT as an initial treatment in treatment-naive HCC patients was evaluated, and ALBI grade was found to be a useful predictor of overall survival.

CANCERS (2022)

Article Oncology

Protocol for the postoperative radiotherapy in N1 breast cancer patients (PORT-N1) trial, a prospective multicenter, randomized, controlled, non-inferiority trial of patients receiving breast-conserving surgery or mastectomy

Tae Hoon Lee, Ji Hyun Chang, Bum-Sup Jang, Jae Sik Kim, Tae Hyun Kim, Won Park, Yong Bae Kim, Su Ssan Kim, Wonshik Han, Han-Byoel Lee, Kyung Hwan Shin

Summary: This study aims to evaluate the possibility and effectiveness of de-escalation of postoperative radiotherapy for pN1 breast cancer patients after breast-conserving surgery or mastectomy. It will compare different radiotherapy strategies in terms of treatment outcomes and toxicity rates, providing important evidence for individualized radiotherapy strategies for pN1 breast cancer patients.

BMC CANCER (2022)

Article Oncology

Stereotactic Ablative Radiotherapy for Oligometastatic Hepatocellular Carcinoma: A Multi-Institutional Retrospective Study (KROG 20-04)

Tae Hyung Kim, Taek-Keun Nam, Sang Min Yoon, Tae Hyun Kim, Young Min Choi, Jinsil Seong

Summary: This multi-institutional retrospective study investigated the clinical efficacy of SABR in patients with oligometastatic hepatocellular carcinoma. The results showed that SABR appeared to be an effective and safe treatment for all metastatic lesions. Patients with good performance status and liver function could achieve long-term survival.

CANCERS (2022)

Article Oncology

Interobserver Variability Prediction of Primary Gross Tumor in a Patient with Non-Small Cell Lung Cancer

Wonjoong Cheon, Seonghoon Jeong, Jong Hwi Jeong, Young Kyung Lim, Dongho Shin, Se Byeong Lee, Doo Yeul Lee, Sung Uk Lee, Yang Gun Suh, Sung Ho Moon, Tae Hyun Kim, Haksoo Kim

Summary: This research introduces a novel IOV prediction network (IOV-Net) that utilizes deep learning to produce high-quality IOV maps, aiming to reduce interobserver variability in oncologists' manual delineation of tumor contours. Experimental results demonstrate that IOV prediction accuracy is high, and clinical feasibility tests show that guidance from IOV maps can significantly reduce IOV and improve radiation therapy efficacy.

CANCERS (2022)

Article Oncology

Clinical Efficacy of Hypofractionated Proton Beam Therapy for Intrahepatic Cholangiocarcinoma

Tae Hyun Kim, Sang Myung Woo, Woo Jin Lee, Jung Won Chun, Yu Ri Cho, Bo Hyun Kim, Young-Hwan Koh, Sang Soo Kim, Eun Sang Oh, Do Yeul Lee, Sung Uk Lee, Yang-Gun Suh, Sung Ho Moon, Joong-Won Park

Summary: This study evaluated the efficacy and safety of hypofractionated proton beam therapy (PBT) in patients with inoperable or recurrent intrahepatic cholangiocarcinoma (IHCC). The findings demonstrated that hypofractionated PBT was tolerated and safe, providing a high rate of local tumor control and promising survival in these patients. For patients with localized disease, the survival outcomes with hypofractionated PBT were comparable to surgical resection.

CANCERS (2022)

No Data Available